Donate Today
If you are a patient or family member or friend in need of immediate assistance:
Jump to the following sections:
[Resources for Psychiatrists] [CDC Information] [COVID-19 & Mental Health] [New Telehealth Rules] [Webinars] [APA’s Practice Management Hotline] [Resources for Families] [Resources for Health Care and Community Leaders]
With COVID-19 evolving rapidly across the world, APA’s Committee on Psychiatric Dimensions of Disasters and the APA’s Council on International Psychiatry compiled the following list of resources for psychiatrists. The resources cover not only the physical impact of the coronavirus, but on its potential mental health and psychosocial issues and responses. The resources also include a section on telepsychiatry, to prepare for the possibility of isolation and/or quarantine.
The U.S. Drug Enforcement Administration issued guidance to DEA-registered physicians providing new flexibility for physicians managing patients with opioid use disorder. The new guidance permits physicians and other health professionals with a waiver allowing them to prescribe buprenorphine for the treatment of opioid use disorder to issue these prescriptions to new and existing patients based on an evaluation via telephone. The new policy is effective from March 31 for the duration of the COVID-19 emergency.
This guidance removes a considerable barrier for many patients during the national emergency and, importantly, allows them to stay at home. The full guidance is available at: https://www.samhsa.gov/sites/default/files/dea-samhsa-buprenorphine-telemedicine.pdf. 4/1/2020
If you are an APA member, APA’s Practice Management HelpLine is ready to assist you with your practice management needs. Help is available on how to manage the day-to-day operations of your practice in the midst of this pandemic, including telehealth, coding, documentation, reimbursement, contracting with managed care companies, Medicare, Medicaid, and more.
What you need to know
Rules regarding the practice of telepsychiatry have changed quickly. CMS released guidance on March 17, 2020, that now allows patients to be seen via live videoconferencing in their homes, without having to travel to a qualifying “originating site” for Medicare telehealth encounters, regardless of geographic location.
To learn more about whether telepsychiatry may be a helpful option for your practice, and to access APA’s collection of resources on telepsychiatry, use the links below:
